跳至主要内容
临床试验/NCT00033085
NCT00033085已完成2 期

Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence

National Institute on Drug Abuse (NIDA)2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2001年5月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
2
主要终点
Cocaine use

研究概览

简要总结

The purpose of this study is to assess the efficacy and safety of ondansetron to reduce cocaine use in subjects with cocaine dependence.

详细描述

Double-blind, placebo-controlled, 4-parallel group design to assess the efficacy and safety of 3 wide range doses of ondansetron to reduce cocaine use in subjects with cocaine dependence and to determine the optimal dose of ondansetron.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male/Female, at least 18 yrs of age; DSM-4 diagnosis of cocaine dependence; seeking Treatment for cocaine dependence; have ability to understand, having understood and provide written consent; females of child bearing potential that use accepted method of birth control

排除标准

  • Additional criteria available during screening at the site.

结局指标

主要结局

Cocaine use

次要结局

未报告次要终点

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验

Ondansetron for the Treatment of Cocaine Dependence... | 临床试验